المؤلفون: E. Brendel, Matthias Ludwig, Caroline Robert, Chetan Lathia, Jean-Charles Soria, Stanislas Ropert, Jean-Pierre Armand

المساهمون: Bayer HealthCare AG, Research Center, Bayer Corporation, Institut Gustave Roussy (IGR), AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris], Institut Claudius Regaud, CRLCC Institut Claudius Regaud, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)

المصدر: Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology, Springer Verlag, 2010, 68 (1), pp.53-61. 〈10.1007/s00280-010-1423-9〉
Cancer Chemotherapy and Pharmacology, Springer Verlag, 2010, 68 (1), pp.53-61. ⟨10.1007/s00280-010-1423-9⟩

مصطلحات موضوعية: Male, Cancer Research, Pyridines, Metabolite, Pharmacology, Toxicology, Tyrosine-kinase inhibitor, chemistry.chemical_compound, 0302 clinical medicine, Neoplasms, AIC, Antineoplastic Combined Chemotherapy Protocols, Medicine, heterocyclic compounds, Pharmacology (medical), ComputingMilieux_MISCELLANEOUS, 0303 health sciences, biology, Benzenesulfonates, Sorafenib, 3. Good health, Dacarbazine, Oncology, Enzyme inhibitor, 030220 oncology & carcinogenesis, Disease Progression, Original Article, Female, medicine.drug, Niacinamide, medicine.drug_class, 03 medical and health sciences, Phase I, Pharmacokinetics, Growth factor receptor, Humans, Protein Kinase Inhibitors, 030304 developmental biology, business.industry, Phenylurea Compounds, Cancer, medicine.disease, Aminoimidazole Carboxamide, chemistry, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc5923473861a3868da6680831fe2c26Test

المؤلفون: Wei Zhou, Lee D. Cranmer, Igor Puzanov, Caroline Robert, Paolo A. Ascierto, Christian U. Blank, Antoni Ribas, April K.S. Salama, Omid Hamid, Steven J. O'Day, Adil Daud, F. Stephen Hodi, Rene Gonzalez, Jacob Schachter, Reinhard Dummer, Peter Soonmo Kang, Dirk Schadendorf, Joy Lis, Nicole Li, Anna C. Pavlick, Scot Ebbinghaus

المصدر: Journal of Translational Medicine

مصطلحات موضوعية: Medicine(all), Chemotherapy, medicine.medical_specialty, Temozolomide, business.industry, Biochemistry, Genetics and Molecular Biology(all), medicine.medical_treatment, Melanoma, Ipilimumab, General Medicine, Pembrolizumab, medicine.disease, Bioinformatics, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, Refractory, Internal medicine, medicine, Oral Presentation, Therapy duration, In patient, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b244a2465aeff5cd7d5e9ef6b7ed366cTest